E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/13/2006 in the Prospect News Biotech Daily.

FDA announces plans for nanotechnology public meeting

By Elaine Rigoli

Tampa, Fla., April 13 - The Food and Drug Administration will be holding a public meeting in the fall of 2006, designed to gather information about current developments in uses of nanotechnology materials in FDA-regulated products.

In a Federal Register notice displayed Thursday, the FDA asks that those interested in presenting at or attending the meeting inform the agency of their interest.

The FDA said it wants to hear about the new types of human and animal drugs, human biologics and medical devices, as well as specific scientific issues related to the development of these products relevant to FDA regulation.

The agency also said it is interested in hearing from companies that are facing hurdles that may be inhibiting the use of nanotechnology in medical product development.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.